Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Communication
  • Published:

Effect of L-carnitine on plasma glycemic and lipidemic profile in patients with type II diabetes mellitus

European Journal of Clinical Nutrition volume 59, pages 592–596 (2005)Cite this article

Abstract

Objective:

We designed this study to investigate the effects of oral L-carnitine administration on fasting plasma glucose (FPG), glycosylated hemoglobin (HbA1c) and lipid parameters in patients with diabetes mellitus type II.

Patients and methods:

The effect of L-carnitine on FPG and lipid parameters was investigated in 22 male and 13 female type II diabetic patients; the mean age±s.d. was 51.3±3.7 y. The patients were randomly allocated to two groups (L-carnitine and placebo group) and 1 g of L-carnitine or of placebo was given orally three times a day for a period of 12 weeks.

Results:

FPG in the L-carnitine group decreased significantly from 143±35 to 130±33 mg/dl (P=0.03), and we observed a significant increase of triglycerides (TG) from 196±61 to 233±12 mg/dl (P=0.05), of Apo A1 from 94±20 to 103±23 mg/dl (P=0.02), and of Apo B100 from 98±18 to 108±22 mg/dl (P=0.02) after 12 weeks of treatment. There was no significant change in LDL-C, HDL-C, HbA1C, LP(a) or total cholesterol.

Conclusion:

L-Carnitine significantly lowers FPG but increases fasting triglyceride in type II diabetic patients.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  • Abdel-aleem S, Karim AM, Zarouk WA, Taylor DA, el-Awady MK & Low JE (1997): Reduced effects of l-carnitine on glucose and fatty acid metabolism in myocytes isolated from diabetic rats. Horm. Metab. Res. 29, 430–435.

    Article  CAS  Google Scholar 

  • Broderick TL, Quinney HA & Lopaschuk GD (1992): Carnitine stimulation of glucose oxidation in the fatty acid perfused isolated working rat heart. J. Biol. Chem. 267, 3758–4636.

    CAS  PubMed  Google Scholar 

  • Capaldo B, Napoli R, Bonito DP, Albano G & Sacca L (1991): Carnitine improves peripheral glucose disposal in non-insulin-dependent diabetic patients. Diab. Res. Clin. Pract. 14, 191–196.

    Article  CAS  Google Scholar 

  • Davis RA & Hui TY (2001): 2000 George Lyman Duff Memorial Lecture: atherosclerosis is a liver disease of the heart. Arterioscler. Thromb. Vasc. Biol. 21, 887–898.

    Article  CAS  Google Scholar 

  • De Palo E, Gatti R, Sicolo N, Padovan D, Vettor R & Federspil G (1981): Plasma and urine free L-carnitine in human diabetes mellitus. Acta Diabetol. Lat. 18, 91–95.

    Article  CAS  Google Scholar 

  • Derosa G, Cicero FGA, Gaddi A, Mugellini A, Ciccarelli L & Fogari R (2003): The effect of L-carnitine on plasma lipoprotein(a) levels in hypercholesterolemic patients with type 2 diabetes mellitus. Clin. Ther. 25, 1429–1439.

    Article  CAS  Google Scholar 

  • Di Donto S, Garavaglia B, Rimoldi M & Carrara F (1992): Clinical and biomedical phenotypes of carnitine deficiencies. In -Carnitine and its Role in Medicine: From Function to Therapy eds. R Ferrari, S Di Mauro, G Sherwood. London: Academic Press.

    Google Scholar 

  • Fritz IB & Marquis NR (1965): The role of acyl-carnitine esters and carnitine palmitoyltransferase in the transport of fatty acyl groups across mitochondrial memberanes. Proc. Natl. Acad. Sci. USA 54, 1226–1230.

    Article  CAS  Google Scholar 

  • Gaetano DA, Mingrone G, Castagneto M & Calvani M (1999): Carnitine increases glucose disposal in humans. J. Am. Coll. Nutr. 18, 289–295.

    Article  Google Scholar 

  • Huang B, Wu P, Popov KM & Harris R (2003): Starvation and diabetes reduce the amount of pyruvate dehydrogenase phosphatase in rat heart and kidney. Diabetes 52, 1371–1376.

    Article  CAS  Google Scholar 

  • Maccari F, Pessotto P, Ramacci T M & Angelucci L (1985): The effect of exogenous L-carnitine on fat diet induced hyperlipidemia in the rat. Life Sci. 36, 1967–1975.

    Article  CAS  Google Scholar 

  • Maebashi M, Kawamura N, Sato M, Imamura A & Yoshinaga K (1978): Lipid-lowering effect of carnitine in patients with type-IV hyperlipoproteinaemia. Lancet 14, 805–807.

    Article  Google Scholar 

  • Mingrone G, Greco VA, Capristo E, Benedetti G, Giancaterini A, Gaetano A & Gasbarrini G (1999): L-carnitine improves glucose disposal in type 2 diabetic patients. J. Am. Coll. Nutr. 18, 77–82.

    Article  CAS  Google Scholar 

  • Nakai N, Miyazaki Y, Sato Y, Oshida Y, Nagasaki M, Tanaka M, Nakashima K & Shimomura Y (2002): Exercise training increases the activity of pyruvate dehydrogenase complex in skeletal muscle of diabetic rats. Endocr. J. 49, 547–554.

    Article  CAS  Google Scholar 

  • Packard CJ & Sheperd J (1995): Metabolic basis of the atherogenic lipoprotein phenotype. In pp 289–294 Multiple Risk Factor in Cardiovascular Disease eds AM Gotto, C Lenfant, AL Catapano, R Paoletti. Dordrecht, Kluwer Academic Publishers.

    Google Scholar 

  • Reymond LT, Reynolds AS, Swanson AJ, Patnode AC & Bell PF (1987): The effect of oral L-carnitine on lipoprotein composition in the Watanabe heritable hyperlipidemic rabbit (Oryctolagus cuniculus). Commun. Biochem. Physiol. 88, 503–506.

    Article  Google Scholar 

  • Rhew TH & Sachan DS (1986): Dose-dependent lipotropic effect of carnitine in chronic alcoholic rats. J. Nutr. 116, 2263–2269.

    Article  CAS  Google Scholar 

  • Rodrigues B, Secombe D & Mcneill JH (1990): Lack of effect oral L-carnitine trearment on lipid metabolism and cardiac function in chronically diabetic rats. Can. J. Phisiol. Pharmacol. 68, 1601–1608.

    Article  CAS  Google Scholar 

  • Rodrigues B, Xiang H & Mcneill HJ (1988): Effect of L-carnitine traerment on lipid metabolism and performance in chronically diabetic rats. Diabetes 37, 1358–1364.

    Article  CAS  Google Scholar 

  • Secombe WD, James L, Hahn P & Jones E (1987): L-Carnitine trearment in the hyperlipidemic rabbit. Metabolism 36, 1192–1196.

    Article  Google Scholar 

  • Sirtori CR, Calabresi L, Ferrara S, Pazzucconi F, Bondioli A, Baldassarre D, Birreci A & Koverech A (2000): L-Carnitine reduces plasma lipoprotein(a) levels in patients with hyper Lp(a). Nutr. Metab. Cardiovasc. Dis. 10, 247–251.

    CAS  PubMed  Google Scholar 

  • Stefanutti C, Vivenzio A, Lucani G, Di Giacomo S & Lucani E (1998): Effect of L-carnitine on plasma lipoprotein fatty acids pattern in patients with primary hyperlipoproteinemia. Clin. Ther. 149, 115–119.

    CAS  Google Scholar 

  • Sugden MC & Holness MJ (2002): Therapeutic potential of the mammalian pyruvate dehydrogenase kinases in the prevention of hyperglycaemia. Curr. Drug Immune Endocr. Metabol. Disord. 2, 151–165.

    Article  CAS  Google Scholar 

  • Tamamogullari N, Silig Y, Icagasioglu S & Atalay A (1999): Carnitine deficiency in diabetes mellitus complications. J. Diab. Complic. 13, 251–253.

    Article  CAS  Google Scholar 

  • Uziel G, Garavaglia B & Di Donato S (1988): Carnitine stimulation of pyruvate dehydrogenase complex (PDHC) in isolated human skeletal muscle mitochondria. Muscle Nerve 11, 720–724.

    Article  CAS  Google Scholar 

  • Vacha MG, Giorcelli G, Siliprandi N & Corsi M (1983): Favorable effects of L-carnitine treatment on hypertriglyceridemia in hemodialysis patiants: decisive role of low levels of high-density lipoprotein-cholestrol. Am. J. Clin. Nutr. 38, 532–540.

    Article  CAS  Google Scholar 

  • Yeh GY, Eisenberg DM, Kaptchuk TJ & Phillips RS (2003): Systematic review of herbs and dietary supplements for glycemic control in diabetes. Diabetes Care 26, 1277–1294.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Human Nutrition, Faculty of Nutrition and Food Technology,

    A R Rahbar, R Shakerhosseini, N Saadat, F Taleban, A Pordal & B Gollestan

  2. Shahid Beheshtee University of Tehran, Tehran, Iran

    A R Rahbar, R Shakerhosseini, N Saadat, F Taleban, A Pordal & B Gollestan

Authors
  1. A R Rahbar
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R Shakerhosseini
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. N Saadat
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. F Taleban
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. A Pordal
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. B Gollestan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A R Rahbar.

Additional information

Guarantor: AR Rahbar.

Contributors: ARR designed the study, collected and analyzed the data and wrote the manuscript. RS, NS, FT, AP and BG helped in collection and analyzing the dates.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rahbar, A., Shakerhosseini, R., Saadat, N. et al. Effect of L-carnitine on plasma glycemic and lipidemic profile in patients with type II diabetes mellitus. Eur J Clin Nutr 59, 592–596 (2005). https://doi.org/10.1038/sj.ejcn.1602109

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.ejcn.1602109

Keywords

Search

Advanced search

Quick links